What is Salvus Labs?
Salvus Labs specializes in providing personalized laboratory services for toxicology and behavioral health drug screening and confirmation testing. The company is dedicated to assisting healthcare providers in meeting stringent monitoring requirements, especially concerning opioid prescriptions. By leveraging advanced technologies, Salvus Labs delivers accurate diagnostic results and supports clinicians in the interpretation and application of this data within their clinical practice. Their focus on high-standard toxicology testing aims to enhance the quality of care for patients, particularly those undergoing pain management.
How much funding has Salvus Labs raised?
Salvus Labs has raised a total of $169K across 1 funding round:
Debt
$169K
Debt (2021): $169K with participation from PPP
Key Investors in Salvus Labs
PPP
Public-Private Partnership
What's next for Salvus Labs?
With its large-scale late-stage funding, Salvus Labs is poised for significant expansion and further technological advancement. The recent strategic investment suggests a focus on scaling operations, potentially broadening its service offerings, and solidifying its market leadership in compliance and diagnostic testing for controlled medications. This capital infusion will likely enable the company to enhance its laboratory capabilities, expand its reach to more healthcare providers, and continue its mission of improving patient care through precise and reliable toxicology services.
See full Salvus Labs company page
